What is Sanofi Consumer Healthcare India Gross Margin %?
Sanofi Consumer Healthcare IndiaNSE:SANOFICONR +0.03%21 Gross Margin % is 75.48% as of Mar. 2026, which is 11% above its 10-year median of 68.05. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 938 Drug Manufacturers companies, Sanofi Consumer Healthcare India ranks better than 86.46% on this metric.
NSE:SANOFICONR's Gross Margin % is ranked better than 86.46% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs NSE:SANOFICONR: 73.53
Sanofi Consumer Healthcare India had a gross margin of 75.48% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Sanofi Consumer Healthcare India (NSE:SANOFICONR) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sanofi Consumer Healthcare India had a gross margin of 75.48% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sanofi Consumer Healthcare India Gross Margin % Related Terms
Sanofi Consumer Healthcare India Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi Consumer Healthcare India Gross Margin % Chart
NSE:SANOFICONR vs LLY, JNJ, ABBV: Gross Margin % Comparison
For the Drug Manufacturers - General subindustry, Sanofi Consumer Healthcare India's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanofi Consumer Healthcare India Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanofi Consumer Healthcare India's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sanofi Consumer Healthcare India's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a Gross Margin % of 75.48% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Sanofi Consumer Healthcare India and its competitors. This is 11% above median its historical median of 68.05. Over the past decade, Sanofi Consumer Healthcare India's Gross Margin % has ranged from 64.36 to 73.53. According to the industry distribution chart, Sanofi Consumer Healthcare India ranks #127 out of 938 companies in the Drug Manufacturers industry, placing it in the top 13.5%.
Is Sanofi Consumer Healthcare India's Gross Margin % too high?
Sanofi Consumer Healthcare India's current Gross Margin % of 75.48% is 11% above median its 10-year median of 68.05. Over the past 10 years, this metric has ranged from a low of 64.36 to a high of 73.53. The Drug Manufacturers industry median Gross Margin % is 48.54. Sanofi Consumer Healthcare India's value of 75.48% is 55.5% above this industry median. Based on the distribution chart, Sanofi Consumer Healthcare India ranks #127 out of 938 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's Gross Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sanofi Consumer Healthcare India ranks #127 out of 938 companies for Gross Margin %. This places Sanofi Consumer Healthcare India in the top 14% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.54. Sanofi Consumer Healthcare India's value of 75.48% is 55.5% above this benchmark. Historically, Sanofi Consumer Healthcare India's own Gross Margin % has ranged from 64.36 to 73.53 over the past decade. While the company's 10-year median is 68.05 vs. the industry median of 48.54, Sanofi Consumer Healthcare India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanofi Consumer Healthcare India's current Gross Margin % of 75.48% is 55.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sanofi Consumer Healthcare India and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanofi Consumer Healthcare India's current Gross Margin % is 75.48%, which is 11% above median its own 10-year median of 68.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current Gross Margin % of 75.48%. The current Gross Margin % is 75.48%, which is 11% above median its 10-year median of 68.05 and 55.5% above the Drug Manufacturers industry median of 48.54. Sanofi Consumer Healthcare India's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current Gross Margin % is 75.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sanofi Consumer Healthcare India Business Description
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
21GF Score
Get the complete analysis for NSE:SANOFICONR
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SANOFICONR has been successfully added to your 
